flumazenil has been researched along with tert-butylbicyclo-2-benzoate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kovács, I; Maksay, G; Simonyi, M | 1 |
Jembrek, MJ; Lazić, J; Pericić, D; Rajcan, I; Strac, DS | 1 |
Lazić, J; Pericić, D; Strac, DS | 1 |
3 other study(ies) available for flumazenil and tert-butylbicyclo-2-benzoate
Article | Year |
---|---|
Inhibition of high-affinity synaptosomal uptake of gamma-aminobutyric acid by a bicyclo-heptane derivative.
Topics: Animals; Anticonvulsants; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Camphanes; Carbolines; Cerebral Cortex; Diazepam; Flumazenil; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Synaptic Membranes; Synaptosomes | 1989 |
Chronic exposure of cells expressing recombinant GABAA receptors to benzodiazepine antagonist flumazenil enhances the maximum number of benzodiazepine binding sites.
Topics: Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Cell Membrane; Diazepam; Dose-Response Relationship, Drug; Drug Combinations; Flumazenil; Flunitrazepam; GABA Modulators; gamma-Aminobutyric Acid; Humans; Kidney; Ligands; Receptors, GABA-A; Recombinant Proteins; Tritium | 2004 |
Chronic treatment with flumazenil enhances binding sites for convulsants at recombinant alpha(1)beta(2)gamma(2S) GABA(A) receptors.
Topics: Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Convulsants; Diazepam; Flumazenil; GABA Modulators; GABA-A Receptor Antagonists; Humans; Receptors, GABA-A; Recombinant Proteins | 2005 |